Compound details
trans-Jasmone
| Compound ID | CDAMM00254 |
|---|---|
| Common name | trans-Jasmone | IUPAC name | 3-methyl-2-[(E)-pent-2-enyl]cyclopent-2-en-1-one |
| Molecular formula | C11H16O |
| Retention time | 27.61 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 165.127 | Theoretical mz | 165.127 |
| Error | 0.55 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.17 |
| Inchi key | FDGQSTZJBFJUBT-UHFFFAOYSA-N |
|---|---|
| Smiles | CCC=CCC1=C(CCC1=O)C |
| Superclass | Organoheterocyclic compounds |
| Class | Imidazopyrimidines |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43681 | CHRNA4 | Neuronal acetylcholine receptor; alpha4/beta2 | T70967 | SwissTargetPrediction |
| P08173 | CHRM4 | Muscarinic acetylcholine receptor M4 | T20709 | SwissTargetPrediction |
| P08912 | CHRM5 | Muscarinic acetylcholine receptor M5 | T79961 | SwissTargetPrediction |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| P07327 | ADH1A | Alcohol dehydrogenase alpha chain | T65570 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P04818 | TYMS | Thymidylate synthase (by homology) | T98397 | SwissTargetPrediction |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P12821 | ACE | Angiotensin-converting enzyme | T98311 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SwissTargetPrediction |
| P31213 | SRD5A2 | Steroid 5-alpha-reductase 2 | T71390 | SwissTargetPrediction |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P34969 | HTR7 | Serotonin 7 (5-HT7) receptor | T79062 | SwissTargetPrediction |
| P43235 | CTSK | Cathepsin K | T11388 | SwissTargetPrediction |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| P05164 | MPO | Myeloperoxidase | T23471 | SwissTargetPrediction |
| P49798 | RGS4 | Regulator of G-protein signaling 4 | T93580 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P08235 | NR3C2 | Mineralocorticoid receptor | T72168 | SwissTargetPrediction |
| P06401 | PGR | Progesterone receptor | T22939 | SwissTargetPrediction |
| P08185 | SERPINA6 | Corticosteroid binding globulin | T88452 | SwissTargetPrediction |
| P18405 | SRD5A1 | Steroid 5-alpha-reductase 1 | T70309 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | T86591 | SwissTargetPrediction |
| Q03181 | PPARD | Peroxisome proliferator-activated receptor delta | T36557 | SwissTargetPrediction |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| Q13547 | HDAC1 | Histone deacetylase 1 | T68547 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P10828 | THRB | Thyroid hormone receptor beta-1 | T98933 | SwissTargetPrediction |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | T46185 | SwissTargetPrediction |
| P07711 | CTSL | Cathepsin L | T98691 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P05093 | CYP17A1 | Cytochrome P450 17A1 | T89041 | SwissTargetPrediction |
| Q99685 | MGLL | Monoglyceride lipase | T18664 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P36897 | TGFBR1 | TGF-beta receptor type I | T53389 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SwissTargetPrediction |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SwissTargetPrediction |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SwissTargetPrediction |
| P08151 | GLI1 | Zinc finger protein GLI1 | T40890 | SwissTargetPrediction |
| O75908 | SOAT2 | Acyl coenzyme A:cholesterol acyltransferase 2 | T14463 | SwissTargetPrediction |
| O60760 | HPGDS | Hematopoietic prostaglandin D synthase | T19433 | SwissTargetPrediction |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SwissTargetPrediction |
| P15559 | NQO1 | Quinone reductase 1 | T52389 | SwissTargetPrediction |
| P10070 | GLI2 | Zinc finger protein GLI2 | T29672 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| Q00975 | CACNA1B | Voltage-gated N-type calcium channel alpha-1B subunit | T38338 | SwissTargetPrediction |
| P48775 | TDO2 | Tryptophan 2,3-dioxygenase | T44818 | SwissTargetPrediction |
| Q9Y6K1 | DNMT3A | DNA (cytosine-5)-methyltransferase 3A | T29355 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T70967 | DI0029 | Aneurysm/dissection | [ICD-11: BD50] | P43681 | CHRNA4 |
| T70967 | DI0191 | Hypertensive crisis | [ICD-11: BA03] | P43681 | CHRNA4 |
| T70967 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P43681 | CHRNA4 |
| T20709 | DI0037 | Asthma | [ICD-11: CA23] | P08173 | CHRM4 |
| T20709 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | P08173 | CHRM4 |
| T20709 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08173 | CHRM4 |
| T20709 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P08173 | CHRM4 |
| T20709 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08173 | CHRM4 |
| T79961 | DI0002 | Abnormal micturition | [ICD-11: MF50] | P08912 | CHRM5 |
| T79961 | DI0032 | Anterior uveitis | [ICD-11: 9A96] | P08912 | CHRM5 |
| T79961 | DI0034 | Appearance/behaviour symptom | [ICD-11: MB23] | P08912 | CHRM5 |
| T79961 | DI0037 | Asthma | [ICD-11: CA23] | P08912 | CHRM5 |
| T79961 | DI0061 | Brain disease | [ICD-11: 8C70-8E61] | P08912 | CHRM5 |
| T79961 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08912 | CHRM5 |
| T79961 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08912 | CHRM5 |
| T79961 | DI0093 | Cognition symptoms/signs/clinical symptom | [ICD-11: MB21] | P08912 | CHRM5 |
| T79961 | DI0105 | Cough | [ICD-11: MD12] | P08912 | CHRM5 |
| T79961 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P08912 | CHRM5 |
| T79961 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P08912 | CHRM5 |
| T79961 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P08912 | CHRM5 |
| T79961 | DI0158 | Gastritis | [ICD-11: DA42] | P08912 | CHRM5 |
| T79961 | DI0162 | General examination | [ICD-11: QA00] | P08912 | CHRM5 |
| T79961 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08912 | CHRM5 |
| T79961 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08912 | CHRM5 |
| T79961 | DI0208 | Infectious gastroenteritis/colitis | [ICD-11: 1A40] | P08912 | CHRM5 |
| T79961 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P08912 | CHRM5 |
| T79961 | DI0307 | Nystagmus | [ICD-11: 9C84] | P08912 | CHRM5 |
| T79961 | DI0315 | Oesophagus motility disorder | [ICD-11: DA21] | P08912 | CHRM5 |
| T79961 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P08912 | CHRM5 |
| T79961 | DI0329 | Pancreatitis | [ICD-11: DC31-DC34] | P08912 | CHRM5 |
| T79961 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P08912 | CHRM5 |
| T79961 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08912 | CHRM5 |
| T79961 | DI0338 | Polyuria | [ICD-11: MF55] | P08912 | CHRM5 |
| T79961 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P08912 | CHRM5 |
| T79961 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P08912 | CHRM5 |
| T79961 | DI0424 | Urgency | [ICD-11: N.A.] | P08912 | CHRM5 |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T65570 | DI0139 | Exposure to noxious substances harmful effect | [ICD-11: NE61] | P07327 | ADH1A |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T98397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04818 | TYMS |
| T98397 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P04818 | TYMS |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T98311 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P12821 | ACE |
| T98311 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P12821 | ACE |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T71390 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P31213 | SRD5A2 |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T79062 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P34969 | HTR7 |
| T79062 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34969 | HTR7 |
| T79062 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P34969 | HTR7 |
| T79062 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P34969 | HTR7 |
| T79062 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P34969 | HTR7 |
| T79062 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P34969 | HTR7 |
| T79062 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P34969 | HTR7 |
| T11388 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P43235 | CTSK |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T23471 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P05164 | MPO |
| T23471 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P05164 | MPO |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T72168 | DI0018 | Adrenocortical insufficiency | [ICD-11: 5A74] | P08235 | NR3C2 |
| T72168 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P08235 | NR3C2 |
| T72168 | DI0100 | Contraceptive management | [ICD-11: QA21] | P08235 | NR3C2 |
| T72168 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08235 | NR3C2 |
| T72168 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08235 | NR3C2 |
| T72168 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P08235 | NR3C2 |
| T22939 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06401 | PGR |
| T22939 | DI0100 | Contraceptive management | [ICD-11: QA21] | P06401 | PGR |
| T22939 | DI0255 | Menstrual cycle bleeding disorder | [ICD-11: GA20] | P06401 | PGR |
| T22939 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P06401 | PGR |
| T22939 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06401 | PGR |
| T88452 | DI0037 | Asthma | [ICD-11: CA23] | P08185 | SERPINA6 |
| T88452 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P08185 | SERPINA6 |
| T88452 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08185 | SERPINA6 |
| T70309 | DI0347 | Prostate disease | [ICD-11: GA91] | P18405 | SRD5A1 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T86591 | DI0187 | Hyperlipidemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q07869 | PPARA |
| T36557 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | Q03181 | PPARD |
| T36557 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q03181 | PPARD |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T68547 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q13547 | HDAC1 |
| T68547 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q13547 | HDAC1 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T98933 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10828 | THRB |
| T46185 | DI0037 | Asthma | [ICD-11: CA23] | P08172 | CHRM2 |
| T46185 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08172 | CHRM2 |
| T46185 | DI0278 | Muscle disorder | [ICD-11: FB32-FB3Z] | P08172 | CHRM2 |
| T46185 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08172 | CHRM2 |
| T46185 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08172 | CHRM2 |
| T46185 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P08172 | CHRM2 |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T89041 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P05093 | CYP17A1 |
| T18664 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q99685 | MGLL |
| T18664 | DI0409 | Tic disorder | [ICD-11: 8A05] | Q99685 | MGLL |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T53389 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P36897 | TGFBR1 |
| T53389 | DI0238 | Lung cancer | [ICD-11: 2C25] | P36897 | TGFBR1 |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T14463 | DI0017 | Adrenal cancer | [ICD-11: 2D11] | O75908 | SOAT2 |
| T19433 | DI0148 | Flatworm infection | [ICD-11: 1F70-1F86] | O60760 | HPGDS |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T52389 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | P15559 | NQO1 |
| T52389 | DI0090 | CNS anomalies syndrome | [ICD-11: LD20] | P15559 | NQO1 |
| T52389 | DI0202 | Inborn energy metabolism error | [ICD-11: 5C53] | P15559 | NQO1 |
| T52389 | DI0215 | Intellectual development disorder | [ICD-11: LD90] | P15559 | NQO1 |
| T52389 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P15559 | NQO1 |
| T52389 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P15559 | NQO1 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T38338 | DI0264 | Migraine | [ICD-11: 8A80] | Q00975 | CACNA1B |
| T38338 | DI0305 | Non-thrombocytopenic purpura | [ICD-11: 3B60] | Q00975 | CACNA1B |
| T38338 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q00975 | CACNA1B |
| T44818 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P48775 | TDO2 |